Urinary tract infections (UTIs) in kidney transplant patients may be caused by bacteria that originate in the digestive tract, according to investigators at Weill Cornell Medicine, Cornell University, and NewYork-Presbyterian.
Dr. David Russell, the William Kaplan Professor of Infection Biology in the Department of Microbiology and Immunology in the Cornell College of Veterinary Medicine, has used a cutting-edge method for illuminating the interaction between the bacteria that cause tuberculosis and two different kinds of host cells.
A researcher investigating the role a certain gene plays in periodontal disease and another studying why some mammals develop breast cancer and others don’t are each winners of a 2020 Schwartz Research Fund for Women and other Underrepresented Faculty in the Life Sciences. Congrats to Angela Poole and Gerlinde Van de Walle for wining this prestigious award.
Shaoyi Jiang, Ph.D. ’93, a professor of chemical engineering at the University of Washington, has been named the first Robert S. Langer ’70 Family and Friends Professor at Cornell. Jiang will join the Nancy E. and Peter C. Meinig School of Biomedical Engineering in July, in a professorship honoring one of the university’s most notable engineering alumni.
A study, published Jan. 3 in the journal Nature Communications, identifies a key pathway in gastric SCJ cancers that provides a promising target for future study and therapy. The researchers found that the progeny of a type of stem cell (Lgr5+) collect in large numbers and promote cancer in areas where two types of stomach tissues meet.
Jan Lammerding is the senior author on new Cornell-led research paper which reports a strong connection between DNA damage triggered by mutations in proteins that surround the cell nucleus, known as lamins, and muscular dystrophy. By exploring the mechanisms that cause the damage, the researchers are hopeful their discovery can help shape better treatments. “Mutant Lamins Cause Nuclear Envelope Rupture and DNA Damage in Skeletal Muscle Cells,” was published Dec. 16 in Nature Materials.
Researchers from the University of Hyderabad in India and the College of Veterinary Medicine have identified a compound that could be part of a strategy to improve the effectiveness of the dengue vaccine.
Researchers are using glowing nanoparticles called C dots to detect multiple cancer markers during surgery in a way that is both precise and safe.
An Immunoprofiling Workshop – sponsored by the Cornell Center for Immunology, Dec. 13 in Stocking Hall – will feature technology experts who will provide case studies and best practices on various core technologies.